Pfizer Inc Archives | Global News Post https://globalnewspost.com/tag/pfizer-inc/ Fastest Global News Portal Fri, 02 May 2025 05:45:28 +0000 en-US hourly 1 https://globalnewspost.com/wp-content/uploads/2025/04/cropped-GLOBAL-NEWS-POST-32x32.png Pfizer Inc Archives | Global News Post https://globalnewspost.com/tag/pfizer-inc/ 32 32 Inside the deal: Roche and Zealand Pharma’s $5.3 billion weight problems drug gambit https://globalnewspost.com/2025/05/inside-the-deal-roche-and-zealand-pharmas-5-3-billion-obesity-drug-gambit/ https://globalnewspost.com/2025/05/inside-the-deal-roche-and-zealand-pharmas-5-3-billion-obesity-drug-gambit/#respond Fri, 02 May 2025 05:19:00 +0000 https://globalnewspost.com/2025/05/inside-the-deal-roche-and-zealand-pharmas-5-3-billion-obesity-drug-gambit/ A view of the signal and emblem of the Roche Holding AG headquarters on April 11, 2025 in Basel, Switzerland. Sedat Suna | Getty Images News | Getty Images COPENHAGEN, Denmark — The ballooning weight problems drug marketplace will have a brand new contender after Roche struck a $5.3 billion deal to broaden Danish biotech Zealand Pharma‘s …

Source

The post Inside the deal: Roche and Zealand Pharma’s $5.3 billion weight problems drug gambit appeared first on Global News Post.

]]> https://globalnewspost.com/2025/05/inside-the-deal-roche-and-zealand-pharmas-5-3-billion-obesity-drug-gambit/feed/ 0 Pfizer CEO says tariff uncertainty is deterring additional U.S. funding in production, R&D https://globalnewspost.com/2025/04/pfizer-ceo-says-tariff-uncertainty-is-deterring-further-u-s-investment-in-manufacturing-rd/ https://globalnewspost.com/2025/04/pfizer-ceo-says-tariff-uncertainty-is-deterring-further-u-s-investment-in-manufacturing-rd/#respond Tue, 29 Apr 2025 17:13:00 +0000 https://globalnewspost.com/2025/04/pfizer-ceo-says-tariff-uncertainty-is-deterring-further-u-s-investment-in-manufacturing-rd/ Albert Bourla, chairman and CEO of Pfizer, speaks at The Wall Street Journal’s Future of Everything Festival in New York City, U.S., May 22, 2024.  Andrew Kelly | Reuters Pfizer CEO Albert Bourla on Tuesday stated uncertainty round President Donald Trump’s deliberate pharmaceutical price lists is deterring the corporate from additional making an investment in …

Source

The post Pfizer CEO says tariff uncertainty is deterring additional U.S. funding in production, R&D appeared first on Global News Post.

]]> https://globalnewspost.com/2025/04/pfizer-ceo-says-tariff-uncertainty-is-deterring-further-u-s-investment-in-manufacturing-rd/feed/ 0